compound glp 1 ending Readout Newsletter: Abeona, Pfizer, Regeneron, AstraZeneca Can You Trust Compounded GLP-1s?

Only specific GLP-1 drugs are licensed by the MHRA, and they must be prescribed by healthcare experts

Evidence suggests GLP-1 therapies may modestly lower blood pressure while improving cardiometabolic risk in patients with diabetes and hypertension.

Adults with diabetes who used a GLP-1 receptor agonist after undergoing kidney transplantation had a decline in BMI and more stable measures of kidney function than those who did not use a GLP-1, according to a speaker

By 2030, the global prevalence of obesity is expected to reach one billion

Note: Anti-Obesity GLP-1s Wegovy and Zepbound

Browse HeySlim for trusted, evidence-based weight loss advice.